Bright Minds Biosciences: Corporate Overview

Bright Minds Biosciences is a small-cap preclinical biosciences company that is attempting to create the next generation of serotonin drugs that will target specific conditions in the brain which lead to mental health problems and neurological ailments. The company’s research staff (plus advisors) is comprised of a large and accomplished group of scientists and doctors, including Ph.Ds. Bright Minds is developing 5-HT2A and 5-HT2C agonists or drug compounds that could potentially be breakthroughs for patients suffering from MDD and other serious disorders.